Vivien Li
Overview
Explore the profile of Vivien Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li V, McKay F, Tscharke D, Smith C, Khanna R, Lechner-Scott J, et al.
CNS Drugs
. 2025 Jan;
39(3):305-320.
PMID: 39792343
Background: Epstein-Barr virus (EBV) is implicated as a necessary factor in the development of multiple sclerosis (MS) and may also be a driver of disease activity. Although it is not...
2.
Li V, Binder M, Purcell A, Kilpatrick T
J Neuroimmunol
. 2024 Apr;
390:578347.
PMID: 38663308
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system resulting from loss of immune tolerance. Many disease-modifying therapies for MS have broad immunosuppressive effects on...
3.
Chataway J, Williams T, Li V, Marrie R, Ontaneda D, Fox R
Lancet Neurol
. 2024 Feb;
23(3):277-301.
PMID: 38365380
Despite the success of disease-modifying treatments in relapsing multiple sclerosis, for many individuals living with multiple sclerosis, progressive disability continues to accrue. How to interrupt the complex pathological processes underlying...
4.
Binder M, Nwoke E, Morwitch E, Dwyer C, Li V, Xavier A, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Dec;
11(2):e200190.
PMID: 38150649
Background And Objectives: HLA-DRB1*15:01 (DR15) and are 2 risk genes for multiple sclerosis (MS). The variant rs7422195 is an expression quantitative trait locus for MERTK in CD14 monocytes; cells with...
5.
Li V, Binder M, Kilpatrick T
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958886
Many treatments for autoimmune diseases, caused by the loss of immune self-tolerance, are broadly immunosuppressive. Dendritic cells (DCs) can be induced to develop anti-inflammatory/tolerogenic properties to suppress aberrant self-directed immunity...
6.
Li V, Roos I, Monif M, Malpas C, Roberts S, Marriott M, et al.
Mult Scler Relat Disord
. 2022 Jun;
63:103913.
PMID: 35661564
Background: The coronavirus disease 2019 (COVID-19) pandemic has precipitated expansion of telemedicine in outpatient management of chronic diseases including multiple sclerosis (MS). Studies conducted pre-pandemic, when telehealth was an alternative...
7.
Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis
Li V, Leurent B, Barkhof F, Braisher M, Cafferty F, Ciccarelli O, et al.
Neurology
. 2022 Mar;
98(18):754-764.
PMID: 35321926
There are few treatments shown to slow disability progression in progressive multiple sclerosis (PMS). One challenge has been efficiently testing the pipeline of candidate therapies from preclinical studies in clinical...
8.
Seery N, Sharmin S, Li V, Nguyen A, Meaton C, Atvars R, et al.
CNS Drugs
. 2021 Apr;
35(8):907-918.
PMID: 33847902
Background: Ocrelizumab safety outcomes have been well evaluated in clinical trials and open-label extension (OLE) studies. However, risk factors for infection in patients with multiple sclerosis (MS) receiving ocrelizumab have...
9.
Vivekanandam V, Li V, Wu T, Dowling R, Roxburgh R, McGuiness B, et al.
BMJ Neurol Open
. 2021 Mar;
1(1):e000019.
PMID: 33681770
Patients with congestive myelopathy due to spinal dural arteriovenous fistula (SDAVF) typically present with progressive sensory and motor disturbance in association with sphincter dysfunction. Spinal MRI usually shows longitudinally extensive...
10.
Li V, Malladi P, Simeoni S, Pakzad M, Everett R, Satukijchai C, et al.
Neurology
. 2020 Oct;
95(21):e2924-e2934.
PMID: 33046610
Objective: To assess the clinical, urodynamic, and neurophysiologic features of patients with persisting bladder, bowel, and sexual dysfunction after transverse myelitis in myelin oligodendrocyte glycoprotein antibody (MOG-Ab) disease. Methods: Patients...